Skip to content
Open access

PathMED: an R toolkit for single-sample molecular scoring and machine learning with omics data

Jul 2026 · Bioinform. · Vol 42 · 0 citations · 65 references
Medicine Computer Science

TL;DR

The benefit of integrating a novel gene set dissection step into the analysis pipeline to resolve disease heterogeneity at the pathway level is demonstrated and the generalisability of machine learning models trained on transcriptomic scores in predicting clinical outcomes when deploying on proteomic scores is shown.

Abstract

Abstract Motivation Molecular scoring is a popular approach for studying pathway-level functional alterations with omics data. Using molecular scores for tasks such as single-sample molecular characterisation, phenotype prediction or disease stratification has several advantages compared to using omics data directly. Molecular scores provide biological interpretability and are more generalisable across datasets, facilitating data integration and machine learning applications. However, numerous scoring methods are available through different software packages, and currently there is a lack of tools to easily use these scores for model training and prediction. Results We developed pathMED, an R/Bioconductor package that unifies various scoring methods in a simple framework. Furthermore, pathMED also contains a machine learning module to train and test models that use the calculated molecular scores to predict clinical outcomes. We demonstrate some of its potential applications in three use cases using public omics data. We showed the generalisability of machine learning models trained on transcriptomic scores in predicting clinical outcomes when deploying on proteomic scores. We also demonstrated the application of transcriptomics scores in predicting breast cancer treatment response and identifying pathways strongly associated to tumour biology and treatment response. Finally, we demonstrated the benefit of integrating a novel gene set dissection step into the analysis pipeline to resolve disease heterogeneity at the pathway level. Availability PathMED is freely available in the Bioconductor repository (https://bioconductor.org/packages/release/bioc/html/pathMED.html). Code to reproduce the analyses is publicly available at https://github.com/GENyO-BioInformatics/pathMED_article.

Read PDF

Similar papers

Open access Aug 2026

MolJam: A Multidimensional Framework for Assessing Molecular Dataset Quality and Its Impact on Machine Learning

It is demonstrated that both dataset quality and data quantity contribute to model performance and, notably, that retaining molecules with incomplete stereochemical information can outperform their removal when the resulting gain in data quantity offsets the quality penalty.

Peng Wang, Zhaoqi Shi, Xufan Gao et al. · 0 citations
Open access Sep 2026

A Systematic Machine Learning Framework for Evaluating and Ranking Omics Layers in Cancer Drug Response Prediction

Cluster analysis showed the importance of well-defined clusters, indicating that while silhouette scores were linked to prediction success, biological variability also played a critical role, indicating that while silhouette scores were linked to prediction success, biological variability also played a critical role.

Sara Amjad, M. M. Sufyan Beg, Mohd. Azhar Aziz · 0 citations
Open access Aug 2026

A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings

This manuscript evaluates sure screening, a class of filter-based feature selection methods which provide analytical guarantees for true feature set retention and identified BcorSIS as the most effective and computationally efficient screening method across various omics datasets.

Erik Vonkaenel, Lisa M. Bramer, J. Flores et al. · 0 citations
Open access Aug 2026

Integrative transcriptomic and machine learning analyses identify NOL7 and TXLNA as candidate blood biomarkers for Parkinson’s disease within an RNA modification-associated co-expression network

Parkinson’s disease (PD) pathogenesis involves complex molecular mechanisms, with emerging evidence implicating RNA modifications (RM). This study sought to explore RM-associated key genes and their roles in PD progression. Transcriptomic datasets GSE6613 (training) and GSE72267 (validation) were analyze...

Mei-Ling Chen, Peng Chen, Liya Suo et al. · 0 citations
Open access Sep 2026

Knowledge-Driven Feature Selection with the Grouping–Scoring–Modeling Framework for Biomarker Discovery in High-Dimensional Transcriptomic Data

The Grouping–Scoring–Modeling (G-S-M) framework is proposed, a knowledge-driven pipeline that anchors feature selection in established disease–gene associations that provides a reproducible computational framework for candidate biomarker discovery.

Malik Yousef, Jens Allmer, Yasin Inal et al. · 0 citations
Open access Aug 2026

Deep DNA and protein level feature integration for robust clinical variant interpretation using probabilistic gradient boosting

A probabilistic gradient boosting model on variant pathogenicity prediction that applies biological characteristics at both level of DNA and protein levels while also scaling the level of uncertainty in clinical decision making is presented.

Karthik V, S. Prejesh, Sumedh Deepak Kudale et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.